Tone mix
Week by week 52 weeks
Share of Regeneron Pharmaceuticals Inc's 527 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Sep 21, 2026 · tone +100Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Rating Upgraded by Wall Street Zen+112
- Week of Dec 22, 2025 · tone -45Wall Street Zen Downgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Hold-66
- Week of Oct 12, 2026 · tone +50Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $780.00+54
- Week of Jul 6, 2026 · tone -66Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?-50
- Week of May 25, 2026 · tone -43Canaccord Cuts PT on Regeneron Pharmaceuticals (REGN), Cites a Disappointing Event-47
- Week of Apr 20, 2026 · tone +75Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $960.00 at TD Cowen+44
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Regeneron Pharmaceuticals Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 6 | +17 |
| Last 30 sessions | 19 | +31 |
| Last 90 sessions | 266 | -11 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- markets.financialcontent.com · 1 outletFinancialContent - What to expect from Regeneron's (REGN) Q3 earningsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| FinancialContent - What to expect from Regeneron's (REGN) Q3 earnings | markets.financialcontent.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletMBL Wealth LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. $REGNNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| MBL Wealth LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. $REGN | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
3 headlines, average tone +33: 1 positive, 2 neutral and 0 negative. Showing all 3.
- www.themarketsdaily.com · 1 outletRegeneron Pharmaceuticals (NASDAQ:REGN) Given New $980.00 Price Target at TD CowenPositive
- www.themarketsdaily.com · 1 outletRegeneron Pharmaceuticals, Inc. $REGN Stock Bought by Lmcg Investments LLCNeutral
- www.tickerreport.com · 1 outletRegeneron Pharmaceuticals, Inc. $REGN Stock Bought by Vest Financial LLCNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $980.00 Price Target at TD Cowen | www.themarketsdaily.com | 1 | Positive |
| Regeneron Pharmaceuticals, Inc. $REGN Stock Bought by Lmcg Investments LLC | www.themarketsdaily.com | 1 | Neutral |
| Regeneron Pharmaceuticals, Inc. $REGN Stock Bought by Vest Financial LLC | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 2 outletsRegeneron Pharmaceuticals, Inc. $REGN Shares Sold by Prime Capital Investment Advisors LLCNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Prime Capital Investment Advisors LLC | www.tickerreport.com | 2 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.insidermonkey.com · 1 outletStrong Dupixent Trajectory Anchors Regeneron Pharmaceuticals' (REGN) Solid Financial ResultsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Strong Dupixent Trajectory Anchors Regeneron Pharmaceuticals' (REGN) Solid Financial Results | www.insidermonkey.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Regeneron Pharmaceuticals Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.